Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.

Piotrowska Z, Isozaki H, Lennerz JK, Gainor JF, Lennes IT, Zhu VW, Marcoux N, Banwait MK, Digumarthy SR, Su W, Yoda S, Riley AK, Nangia V, Lin JJ, Nagy RJ, Lanman RB, Dias-Santagata D, Mino-Kenudson M, Iafrate AJ, Heist RS, Shaw AT, Evans EK, Clifford C, Ou SI, Wolf B, Hata AN, Sequist LV.

Cancer Discov. 2018 Dec;8(12):1529-1539. doi: 10.1158/2159-8290.CD-18-1022. Epub 2018 Sep 26.

PMID:
30257958
2.

Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.

Noy-Lotan S, Dgany O, Lahmi R, Marcoux N, Krasnov T, Yissachar N, Ginsberg D, Motro B, Resnitzky P, Yaniv I, Kupfer GM, Tamary H.

Haematologica. 2009 May;94(5):629-37. doi: 10.3324/haematol.2008.003327. Epub 2009 Mar 31.

3.

EGF receptor activity is essential for adhesion-induced stress fiber formation and cofilin phosphorylation.

Marcoux N, Vuori K.

Cell Signal. 2005 Nov;17(11):1449-55. Epub 2005 Mar 31.

PMID:
16125057
4.
5.

Suppression of the profilin-deficient phenotype by the RHO2 signaling pathway in Saccharomyces cerevisiae.

Marcoux N, Cloutier S, Zakrzewska E, Charest PM, Bourbonnais Y, Pallotta D.

Genetics. 2000 Oct;156(2):579-92.

6.

Overexpression of MID2 suppresses the profilin-deficient phenotype of yeast cells.

Marcoux N, Bourbonnais Y, Charest PM, Pallotta D.

Mol Microbiol. 1998 Jul;29(2):515-26.

Supplemental Content

Loading ...
Support Center